BBIXF (Bonus BioGroup) Days Payable: 0.00 (As of Dec. 2025)


BBIXF Bonus BioGroup Ltd BBIXF
30 GF Score
Price $0.11
! 3 Warning Signs
View Full Analysis

What is Bonus BioGroup Days Payable?

Bonus BioGroup BBIXF 30 Days Payable is 0.00 as of Dec. 2025. GuruFocus rates BBIXF with a GF Score™ of 30/100. The stock has 3 warning signs investors should review. Among 700 Biotechnology companies, Bonus BioGroup ranks worse than 142857% on this metric.

Bonus BioGroup's average Accounts Payable for the six months ended in Dec. 2025 was $0.52 Mil. Bonus BioGroup's Cost of Goods Sold for the six months ended in Dec. 2025 was $0.00 Mil.

The historical rank and industry rank for Bonus BioGroup's Days Payable or its related term are showing as below:

During the past 13 years, Bonus BioGroup's highest Days Payable was 369.79. The lowest was 175.81. And the median was 298.83.

BBIXF's Days Payable is not ranked *
in the Biotechnology industry.
Industry Median: 112.83
* Ranked among companies with meaningful Days Payable only.

Bonus BioGroup's Days Payable stayed the same from Dec. 2024 (0.00) to Dec. 2025 (0.00).


Bonus BioGroup Days Payable Historical Data

* Premium members only.

The historical data trend for Bonus BioGroup's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bonus BioGroup Days Payable Chart

Bonus BioGroup Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 247.36 322.48 207.48 175.92 0.00

Bonus BioGroup Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BBIXF vs VRTX, REGN, ALNY: Days Payable Comparison

For the Biotechnology subindustry, Bonus BioGroup's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bonus BioGroup Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bonus BioGroup's Days Payable distribution charts can be found below:

* The bar in red indicates where Bonus BioGroup's Days Payable falls into.


BBIXF
30GF Score
Bonus BioGroup Ltd BBIXF
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bonus BioGroup Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Bonus BioGroup's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

Days Payable (A: Dec. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2024 ) + Accounts Payable (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (0.336 + 0.609) / 2 ) / 0*365
=0.4725 / 0*365
=N/A

Bonus BioGroup's Days Payable for the quarter that ended in Dec. 2025 is calculated as:

Days Payable (Q: Dec. 2025 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Jun. 2025 ) + Accounts Payable (Q: Dec. 2025 )) / count ) / Cost of Goods Sold (Q: Dec. 2025 )*Days in Period
=( (0.422 + 0.609) / 2 ) / 0*365 / 2
=0.5155 / 0*365 / 2
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 0.00 mean?
Bonus BioGroup (BBIXF) has a Days Payable of 0.00 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Bonus BioGroup and its competitors. Over the past decade, Bonus BioGroup's Days Payable has ranged from 175.81 to 369.79. According to the industry distribution chart, Bonus BioGroup ranks #999999 out of 700 companies in the Biotechnology industry.
Is Bonus BioGroup's Days Payable too high?
Bonus BioGroup's current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 175.81 to a high of 369.79. Based on the distribution chart, Bonus BioGroup ranks #999999 out of 700 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Bonus BioGroup has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Bonus BioGroup's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Bonus BioGroup ranks #999999 out of 700 companies for Days Payable. This places Bonus BioGroup in the lower half of its industry. The industry median Days Payable is 112.83. Historically, Bonus BioGroup's own Days Payable has ranged from 175.81 to 369.79 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 112.83, based on 700 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Bonus BioGroup and its competitors. For the Biotechnology industry, the median Days Payable is 112.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bonus BioGroup's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bonus BioGroup stock overvalued right now?
Bonus BioGroup (BBIXF) has a current Days Payable of 0.00. The current Days Payable is 0.00. Bonus BioGroup's overall GF Score™ is 30/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Bonus BioGroup (BBIXF), the current Days Payable is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bonus BioGroup Business Description

Other Exchanges BONS:Israel
Address Matam Advanced, Technology Park, P.O.B 15143, Haifa, ISR, 31905
Bonus BioGroup Ltd is an clinical-stage biotechnology company developing next-generation therapies for a variety of indications in the regenerative medicine field. Its products products, BonoFill and MesenCure.
30GF Score

Get the complete analysis for BBIXF

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.11
Price